Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View

E-ISSN： 2212-6988|4|2|93-103

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.4, Iss.2, 2018-01, pp. : 93-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Copy Number Profiles Correlate with Outcome in Colorectal Cancer Patients Treated with Fluoropyrimidine/Antifolate-based Regimens

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 956-965

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Drug Therapy in the Treatment of Colorectal Cancer

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2701-2709

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1713-1719

Bentham Science Publishers

Access to resources Recommend Favorite

Vegetarian diet associated with lower risk of colorectal cancer

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2667-2667

Blackwell Publishing

Access to resources Recommend Favorite

Glutathione and Glutathione-Related Enzymes in Colorectal Cancer Patients

By Saygili Eyüp Ilker Akcay Tülay Konukoglu Dildar Papilla Ciĝdem

Journal of Toxicology and Environmental Health, Vol. 66, Iss. 5, 2003-01 ,pp. : 411-415

Taylor & Francis Ltd

Access to resources Recommend Favorite